| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |